Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 3/2005

01-06-2005 | Case Report

Pleural amyloidosis as the first sign of IgD multiple myeloma

Authors: Christian Hubert Roux, V. Breuil, O. Brocq, L. Euller-Ziegler

Published in: Clinical Rheumatology | Issue 3/2005

Login to get access

Abstract

We describe a case of IgD myeloma with amyloid and plasmocytic pleural localisations. At the onset of the disease it mimicked rheumatoid arthritis, which can be the first presentation of both AL amyloidosis and multiple myeloma. Pleural effusion can happen first in IgD myeloma, but our observation is of interest in that it confirms the very rare possibility of pleural amyloid and plasmocytic localisations devoid of pleural effusion.
Literature
1.
Quinquenel ML, Le Coz A, Desrues B, Caulet-Maugendre S, Lena H, Belleguic C, Lineau C, Delaval P (1996) Pleural amyloidosis. Apropos of a case and review of the literature (in French). Rev Pneumol Clin 52:39–41PubMed
2.
Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH (2003) Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest 124:969–977CrossRefPubMed
3.
Maeno T, Sando Y, Tsukagoshi M, Suga T, Endo M, Seki R, Ooyama Y, Yamagishi T, Kaneko Y, Kanda T, Iwasaki T, Kurabayashi M, Nagai R (2000) Pleural amyloidosis in a patient with intractable pleural effusion and multiple myeloma. Respirology 5:79–80CrossRefPubMed
4.
Cohen AS, Canoss JJ (1975) Rheumatological aspects of amyloid disease. Clin Rheum Dis 1:149–161
5.
Fautrel B, Fernaud JP, Sibilia J, Nochy D, Rousselin B, Ravaud P (2002) Amyloid arthropathy in the course of multiple myeloma. J Rheumatol 29:1473–1788PubMed
6.
Fujishima M, Komatsuda A, Imai H, Wakui H, Watanabe W, Sawada K (2003) Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma. Intern Med 42:121–124PubMed
7.
Fautrel B, Fermand JP, Sibilia J, Nochy D, Rousselin B, Ravaud P (2002) Amyloid arthropathy in the course of multiple myeloma. J Rheumatol 29:1473–1481PubMed
8.
Maachi M, Fellahi S, Diop ME, Francois T, Capeau J, Bastard JP (2003) Pleural effusion as a first sign of IgD lambda multiple myeloma. Ann Med Int 154:70–72
Metadata
Title
Pleural amyloidosis as the first sign of IgD multiple myeloma
Authors
Christian Hubert Roux
V. Breuil
O. Brocq
L. Euller-Ziegler
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-1030-4

Other articles of this Issue 3/2005

Clinical Rheumatology 3/2005 Go to the issue

Review

Have traditional DMARDs had their day?

Letter

Prognostic factors of low bone mineral density in ankylosing spondylitis

Original Article

Ultrasonographic evaluation of tendons and enthesal sites in rheumatoid arthritis: comparison with ankylosing spondylitis and healthy subjects

Original Article

Intra- and interobserver variability of Kleerekoper’s method in vertebral fracture assessment

Case Report

ENT Wegener’s granulomatosis can hide severe central nervous system involvement

Original Article

Relationship between clinically detected joint swelling and effusion diagnosed by ultrasonography in elbow joints in patients with rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits